GENEREX BIOTECHNOLOGY CORP: GNBT (Nasdaq Capital Market)
Enter your Email for a Free Trial: 
Free Trial
Form (Filer)  Received ( Period
4 GENEREX BIOTECHNOLOGY CORP(PERRI ROSE C  11/16/09 (11/16/09) 
4 GENEREX BIOTECHNOLOGY CORP(GLUSKIN ANNA E  11/16/09 (11/16/09) 
4 GENEREX BIOTECHNOLOGY CORP(FLETCHER MARK  11/16/09 (11/13/09) 
4 GENEREX BIOTECHNOLOGY CORP(MASTERSON NOLA E  11/16/09 (11/13/09) 
4 GENEREX BIOTECHNOLOGY CORP(MASTERSON NOLA E  11/13/09 (11/12/09) 
8-K GENEREX BIOTECHNOLOGY CORP  11/10/09 (11/09/09) 
8-K GENEREX BIOTECHNOLOGY CORP  10/30/09 (10/29/09) 
S-8 POS GENEREX BIOTECHNOLOGY CORP  10/26/09 
8-K GENEREX BIOTECHNOLOGY CORP  10/23/09 (10/20/09) 
8-K GENEREX BIOTECHNOLOGY CORP  10/20/09 (10/20/09) 
4 GENEREX BIOTECHNOLOGY CORP(MASTERSON NOLA E  10/19/09 (10/19/09) 
424B5 GENEREX BIOTECHNOLOGY CORP  10/15/09 
8-K GENEREX BIOTECHNOLOGY CORP  10/15/09 (10/14/09) 
10-K GENEREX BIOTECHNOLOGY CORP  10/14/09 (07/31/09) 
8-K GENEREX BIOTECHNOLOGY CORP  10/14/09 (10/14/09) 
8-K GENEREX BIOTECHNOLOGY CORP  10/14/09 (10/14/09) 
8-K GENEREX BIOTECHNOLOGY CORP  10/01/09 (10/01/09) 
8-K GENEREX BIOTECHNOLOGY CORP  09/15/09 (09/14/09) 
424B5 GENEREX BIOTECHNOLOGY CORP  09/14/09 
8-K GENEREX BIOTECHNOLOGY CORP  08/06/09 (08/06/09) 
 
 Results 1 - 20 of 350
     [1] 2 3 4 5 6 7 8 9 10   Next 8 Pages [ Show Next 20 Results ] 
Last Trade
Last Trade: 
$0.50  
Change: 
-0.01 (-1.96%)  
Trade Time: 
Nov 20  
Market Cap: 
$123.47M
Company People
View Officers and Directors and Other Key Individuals Mentioned in GENEREX BIOTECHNOLOGY CORP SEC Filings

Premium Content from Alacrastore.com